Unstable angina is it time for a requiem?

Circulation

Volumn 127, Issue 24, 2013, Pages 2452-2456

  Braunwald, Eugene ^a,b   Morrow, David A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angina; Troponin; Unstable

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATINE KINASE MB; FIBRINOGEN RECEPTOR; TROPONIN;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; ELECTROCARDIOGRAM; HEART MUSCLE NECROSIS; HUMAN; ISCHEMIC HEART DISEASE; MUSCLE CELL; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; REVIEW; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; TROPONIN;

ANGINA, STABLE; ANGINA, UNSTABLE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NECROSIS; TROPONIN;

EID: 84879290496     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001258     Document Type: Review

References (45)

1. Heberden W. Some account of a disorder of the breast Med Trans Coll Physicians London. 1772;2:59-67.
2. Parry CH. An inquiry into the symptoms and cause of the syncope anginosa, commonly called angina pectoris. London, UK: R. Cutwell; 1790.
3. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;59:2015-2020.
4. Sampson JJ, Eliaser M Jr. The diagnosis of impending acute coronary artery occlusion. Am Heart J. 1937;13:675-686.
5. Feil H. Preliminary pain in coronary thrombosis. Am J Med. Sci. 1937;193;42-48.
6. Wood P. Therapeutic applications of anticoagulants. Trans Med Soc London. 1948;13:80-85.
7. Friedberg CK. Acute coronary insufficiency. In: Diseases of the Heart. Philadelphia, PA: WB Saunders; 1956:461-464.
8. World Health Organization, Working Group on the Establishment of Ischemic Heart Disease Registers. Report of the Fifth Working Group, Copenhagen. In: Report No. Eur 8201 (5). Geneva, Switzerland: World Health Organization; 1971.
9. Fowler NO. "Preinfarctional" angina: a need for an objective definition and for a controlled clinical trial of its management. Circulation. 1971;44:755-758.
10. Conti CR, Greene B, Pitt B., et al Coronary surgery in unstable angina pectoris [abstract]. Circulation. 1971;44(suppl II):II-154.
11. Braunwald E, Jones RH, Mark D.B., Brown J., Brown L, Cheitlin MD, Concannon C.A., Cowan M., Edwards C, Fuster V, Goldman L., Green, LA, Grines C.L., Lytle BW, McCauley KM, Mushlin AI, Rose G.C., Smith EE 3rd, Swain JA, Topol EJ, Willerson JT. Diagnosing and managing unstable angina. Circulation. 1994;90:613-622.
12. Braunwald E. Unstable angina: a classification. Circulation. 1989;80: 410-414.
13. Campeau L. Grading of angina pectoris. Circulation. 1975;54:522-523.
14. Braunwald E, Antman EM, Beasley J.W., Califf RM, Cheitlin MD, Hochman JS, Jones R.H., Kerieiakes D., Kupersmith J, Levin TN, Pepine C.J., Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P. ACC/AHA guidelines for the management of patients with unstable angina-non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970-1062.
15. Mendis S, Thygesen K, Kuulasmaa K., Giampaoli S, Mahonen M, Blackett K.N., Lisheng L. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2011;40:139-146.
16. TIMI III B Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI III B Trial. Circulation. 1994;89:1545-1556.
17. Antman EM, Tanasijevic MJ, Thompson B, Schactman M., McCabe CH, Cannon CP, Fischer GA, Fung A.Y., Thompson C., Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
18. Alexander JH, Sparapani RA, Mahaffey K.W., Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia S.L., Boland JB, Simoons ML, Califf RM, Topol E.J., Harrington RA Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA. 2000;283:347-353.
19. Morrow DA, Cannon CP, Jesse R.L., Newby LK, Ravkilde J, Storrow AB, Wu A.H., Christenson RH, Apple FS, Francis G, Tang W; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53:552-574.
20. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333-1344.
21. Katus HA, Remppis A, Looser S., Hallermeier K, Scheffold T, Kübler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol. 1989;21:1349-1353.
22. Thygesen K, Alpert JS, Jaffe A.S., Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-2567.
23. Antman EM. ST-segment elevation myocardial infarction: pathology, pathophysiology and clinical features. In: Bonow RO, et al, eds. Braunwald's Heart Disease. 9th ed. Phliadelphia, PA: Elsevier; 2012:1104.
24. Antman EM. Decision making with cardiac troponin tests. N Engl J Med. 2002;346:2079-2082.
25. Jaffe AS, Babiun L, Apple FS Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006;48:1-11.
26. Morrow DA, Antman EM, Tanasijevic M, Rifai N., de Lemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000;36:1812-1817.
27. Anderson JL, Adams CD, Antman E.M., Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1-e157.
28. Morrow DA, Cannon CP, Rifai N, Frey M.J., Vicari R., Lakkis N, Robertson DH, Hille D.A., DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub W.S., Braunwald E; TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA. 2001;286:2405-2412.
29. Hamm CW, Heeschen C, Goldmann B., Vahanian A, Adgey J, Miguel C.M., Rutsch W., Berger J, Kootstra J, Simoons ML Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999;340:1623-1629.
30. Bertrand ME, Simoons ML, Fox K.A., Wallentin LC, Hamm CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406-1432.
31. Christenson RH, Bunk DM, Schimmel H, Tate JR; IFCC Working Group on Standardization of Troponin I. Point: put simply, standardization of cardiac troponin I is complicated. Clin Chem. 2012;58:165-168.
32. Apple FS, Jesse RL, Newby L.K., Wu AH, Christenson RH, Cannon CP, Francis G, Morrow D.A., Ravkilde J., Storrow AB, Tang W, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F., Panteghini M, Tate J; IFCC Committee on Standardization of Markers of Cardiac Damage; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem. 2007;53:547-551.
33. Newby LK, Jesse RL, Babb J.D., Christenson RH, De Fer TM, Diamond GA, Fesmire FM, Gersh BJ, Geraci S.A., Larsen GC, Kaul S, McKay CR, Philippides G.J., Weintraub WS ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations. J Am Coll Cardiol. 2012;60:2427-2463.
34. Bonaca M, Scirica B, Sabatine M., Dalby A, Spinar J, Murphy S.A., Jarolim P., Braunwald E, Morrow DA Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55:2118-2124.
35. Mills NL, Churchhouse AM, Lee K.K., Anand A., Gamble D, Shah AS, Paterson E, MacLeod M., Graham C, Walker S, Denvir M.A., Fox KA, Newby DE Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA. 2011;305:1210-1216.
36. Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54-61.
37. Wilson SR, Sabatine MS, Braunwald E, Sloan S., Murphy SA, Morrow DA Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Am Heart J. 2009;158:386-391.
38. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J. 2009;30:162-169.
39. O'Malley R.G., Bonaca M, Sabatine M., Scirica B, Jarolim P, Conrad M., Murphy S, Braunwald E, Morrow D. Prognostic performance of a single-molecule high-sensitivity cardiac troponin assay after non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36 [abstract]. J Am Coll Cardiol. 2012;59:e402.
40. O'Malley R.G., Morrow DA, Bonaca M.P., Jarolim P., Scirica BM, Murphy SA, Conrad MJ, Cannon C.P., Braunwald E., Sabatine MS Determination of cardiac troponin with a single-molecule high-sensitivity assay and outcomes in patients with stable coronary artery disease: analysis from PROVE IT-TIMI 22 [abstract]. Circulation. 2012;126:A11559.
41. th percentile for clinical decisionmaking. Clin Chem. 2009;55:85-92.
42. de Lemos J.A., Drazner MH, Omland T, Ayers C.R., Khera A., Rohatgi A, Hashim I, Berry J.D., Das SR, Morrow DA, McGuire DK Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503-2512.
43. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski K.A., Tjora S., Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer M.A., Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538-2547.
44. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57:2406-2408.
45. O'Gara P.T., Kushner FG, Ascheim D.D., Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin B.A., Granger CB, Krumholz HM, Lidmnerbaum JA, Morrow D.A., Newby LK, Ornato JP, Ou N, Radfod M.J., Tamis-Holland JE, Tommaso CL, Tracy C.M., Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary Circulation. 2013;127:529-555.